Skip to main navigation Skip to search Skip to main content

The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1[beta]-induced suppression of islet insulin secretion in vitro

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)39-44
Number of pages6
JournalPancreas
Volume28
Issue number2
Publication statusPublished - Mar 2004

Cite this